Socio-economic impact of tocilizumab (TCZ), other bDMARD and tsDMARD treatment on Japanese Rheumatoid Arthritis patients

Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2021
This article has no abstract
Epistemonikos ID: 5f42a955f00bd3b01e42d92833c56d516843bedb
First added on: Apr 09, 2025